Skip to main content
Premium Trial:

Request an Annual Quote

AMEX Rules Require Bio-Rad to Replace Deceased Director in 90 Days

NEW YORK (GenomeWeb News) — Bio-Rad Laboratories today said it is not in compliance with American Stock Exchange listing requirements after the death of a director last week left the company without the required number of audit committee members.
 
Bio-Rad said it was expecting the letter, which it received on Jan. 9, after notifying AMEX on Jan. 4 of the death of the director, Philip Padou. Companies listed on the AMEX are required to have at least three members on their audit committee.
 
Bio-Rad has three months, or until April 9, to fill Padou’s spot on the committee. The company said it is seeking a replacement.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.